Background: Nasal and sinus symptoms (NSS) are common to many health condi-
sinonasal mucosal inflammation (eg, via sinus computed tomography [CT] ). For epidemiologic studies, EPOS only requires the presence of subjective symptoms (we designate as EPOS S ). 1, 2 Difficulties in obtaining objective evidence of inflammation have been an impediment to large-scale, population-based epidemiologic studies. Depending on individual characteristics, onset, duration, and season, the sudden onset or worsening of NSS could be an indication for allergic rhinitis (AR), acute rhinosinusitis (ARS), an acute exacerbation of chronic rhinosinusitis (AECRS), or other related diagnoses. Published studies of exacerbation among CRS patients have primarily focused on bacteriology, [9] [10] [11] immunology, 12, 13 and medical treatments, [14] [15] [16] [17] as opposed to population-based occurrence, severity, risk factors, and natural history. The International Consensus
Statement on Allergy and Rhinology (ICAR), therefore, has declared a need for prevalence estimates of AECRS and more prospective studies, especially those which compare several definitions of AECRS. 2 As such, the objectives of this study were to evaluate and compare seasonal prevalence of AENSS by EPOS S CRS status (hereafter CRS status) across 3 definitions of AENSS; describe NSS severity by CRS and AENSS status; and identify self-reported individual characteristics associated with AENSS by CRS status. We addressed these objectives in a population-based longitudinal study using a sample of primary care patients from Geisinger who are representative of the general population in the area of central and northeastern Pennsylvania.
| MATERIALS AND METHODS

| Study overview
Details of the study design have been published elsewhere. 5, 18 Briefly, in 2014, adult (at least 18 years of age) primary care patients were selected from the electronic health record (EHR) of Geisinger to participate in a study of the epidemiology of CRS. Individuals who responded to the baseline questionnaire were additionally mailed 4 seasonal follow-up questionnaires over the course of 16 months, to evaluate seasonal exacerbations (Table 1 ; eg, questionnaire see Data S1). This study was approved by the Institutional Review Board (IRB) of Geisinger, which has an IRB Authorization Agreement with the Johns Hopkins Bloomberg School of Public Health. Health Insurance Portability and Accountability Act authorization and written informed consent waivers were approved by the IRB.
| Study population
Geisinger provides primary care services to over 450 000 patients, with the majority residing in central and northeastern Pennsylvania.
The source population for this study consisted of 200 769 adult primary care patients who had available EHR data, including race/ethnicity. Stratified sampling was utilized to over represent individuals more likely to have CRS, as well as racial/ethnic minorities (8% of Geisinger patients identify as non-white race/ethnicity). From the source population, 23 700 individuals were selected to participate in the baseline survey and baseline responders (n = 7847) were mailed 4 follow-up questionnaires with 4-month intervals in-between (Table 1) .
| Description of sampling method
The sampling method has been reported previously. 5, 18 Briefly, individuals with a greater likelihood of having CRS were over-sampled using EHR data to categorize individuals into 3 groups, based on international classification of disease (ICD)-9 codes as well as current procedural terminology codes from patient medical records for CRS, asthma, AR, sinus procedures, and related information. 18 Oversampling of racial and ethnic minorities was also performed. Sampling proportions are reported elsewhere. 5 
| CRS classification
Individuals were classified as having EPOS S CRS as previously reported. 5, 18 In brief, CRS status was determined using subject responses concerning the frequency of the cardinal symptoms of CRS (nasal congestion/blockage, green/yellow nasal discharge [purulence], postnasal drip, smell loss, facial pain, and facial pressure), as defined by EPOS. 1 Based on responses to these questions at the baseline and first follow-up questionnaires, subjects were classified as "current long-term" (current CRS at both questionnaires), "current recent" (past or never CRS at baseline, current CRS at follow-up),
"past" (past CRS at baseline, not current at follow-up), or "never" (no CRS at either questionnaire). Only these questionnaires were used for determining CRS status in this study because 2 of the follow-up questionnaires (winter and spring exacerbation) did not include questions about EPOS symptoms over the past 3 months, and we did not want to induce reverse causality in the association of CRS status and exacerbation. We did not differentiate between CRS with and without nasal polyps as objective evidence of CRS was unavailable for all study participants and therefore no way to reliably phenotype these subjects.
| Operationalization of NSS severity and AENSS
NSS severity was assessed in 2 different ways. The first used selfreported rating of NSS on a 10-point visual analog scale while the second used self-report of having "worse" or "much worse" NSS on a 5-point Likert scale. 1 Using consensus recommendations 1,2 and prior evidence on CRS exacerbations, [9] [10] [11] 13, 15, 19 we operationalized 3 definitions for the classification of AENSS (see Table S1 ). All definitions required participants to self-report worsened NSS in the past 4 weeks. "AENSSMed" defined exacerbation was based on self-reported medication use for worsened NSS. We only used antibiotics and oral corticosteroids as qualifying medications as these are unlikely to be prescribed for viral infections, thereby minimizing potential misclassification of AENSS as common colds. This definition is also parallel to the medical management recommended for asthma 
| Statistical analyses
Given the paucity of information regarding NSS and AENSS by EPOS S CRS status, the goals of the analysis were to (i) assess differ- Survey-corrected methods were used for all analyses to account for the sampling design. Design weights were the inverse product of the probability of being selected into the study and probability of responding to the baseline questionnaire. Additionally, survey weights were corrected for attrition by estimating inverse probability of censoring weights (see Data S2). As CRS status was not ascertained at all time points, CRS status at the first follow-up questionnaire was used for all follow-up questionnaires. Subjects who skipped a questionnaire (23.9%) were excluded from all subsequent questionnaires to avoid intermittent missingness.
Risk factor analysis consisted of inverse probability-weighted generalized estimating equations logistic regression models assuming an independence working correlation matrix and incorporated stabi- Secondary CRS indicates more specific questions about NSS frequency and severity not included as part of the diagnostic criteria for CRS.
Covariates were identified as being a risk factor if they retained statistical significance in adjusted models and were not a priori determined to be a confounder. Methods for assessing model fit are limited in multiply imputed survey-based regression models. However, model fit was assessed by visual inspection of deviance residuals vs predicted probabilities (from weighted candidate final models) and using Archer-Lemeshow tests for goodness of fit. To assess the utility of the multiple imputations, Monte Carlo error estimates were generated for all effect estimates and associated test statistics. All analyses were conducted in STATA 14.1 (StataCorp, College Station, TX, USA).
3 | RESULTS
| Description of participants
Baseline characteristics of the study population have been described elsewhere. 5, 18 A total of 558 current long-term, 273 current recent, 1644 past, and 2261 never EPOS S CRS individuals contributed at least 1 observation to the analysis ( Table 2 ). The general trends in Table 2 suggest individuals with AENSS appeared to be younger, white, female, on medical assistance, and have greater Charlson comorbidity index values, compared to those without AENSS (Table 2 ). The prevalence of AENSS increased from the lowest in the never group, to intermediate in the past and current recent CRS groups, to the highest in the current long-term CRS status group (Table 2) . AENSS recurrence, as identified through the 4 follow-up questionnaires, was the least common in the never group and the most common in the current long-term CRS group (see Table S2 ).
| Severity of nasal and sinus symptoms
Mean NSS severity scores varied by CRS group and exacerbation status ( Figure 1 ; Table S3 ). There were statistically significant associations between CRS status and NSS severity (Table S3) . Mean NSS scores increased ordinally from the lowest score in the never CRS group to the highest score in the current long-term CRS group, where those who were having AENSS had higher NSS severity than those who were not (P < .001 for all CRS status groups). Mean NSS severity scores by AENSS-Med and AENSS-Sx-Pur defined exacerbations were greater than in AENSS-Sx ( Figure 1 ; Table S3 ).
| Seasonal prevalence of AENSS
Prevalence estimates of AENSS by CRS status and AENSS definition were estimated for each season ( Figure 2 ; Table S4 ). The seasonal peak prevalence for exacerbation consistently occurred in the winter for past CRS status and in spring for never CRS status. Seasonal trends were comparable between AENSS-Sx and -Sx-Pur for the current long-term and current recent CRS groups, with peak prevalence occurring in the winter for the current recent CRS group, and a modest peak in the summer for the current long-term CRS group (Figure 2 ; Table S4 ).
| Individual characteristic and seasonal risk factors for AENSS
Risk factor analysis proceeded with 2 of the 3 AENSS definitions (AENSS-Med and -Sx-Pur). We did not include AENSS-Sx as prevalence estimates were much greater from this definition compared to AENSS-Med and -Sx-Pur, which were both comparable, indicating a low relative specificity of AENSS-Sx compared to the other definitions. Tables 3 and 4 show the adjusted odds ratios (aORs) and 95%
CIs for several covariates estimated from logistic regression models.
Several significant and elevated odds ratios were identified in relation to AENSS-Med (Table 3 ) for higher BMI, being a current smoker, having asthma or migraine symptoms at baseline, doctor diagnosed hay fever, having had 2 or more sinus surgeries, and winter season. As CRS status was found to modify associations of season with AENSS-Med, associations are displayed within strata of CRS status (Table 3) .
Elevated odds ratios of risk factors with AENSS-Sx-Pur (Table 4) were found for white race/ethnicity, BMI, having asthma symptoms AENSS-Sx-Pur = worse/much worse NSS in past 4 wks + worse over any time period up to 4 wks + remained worse for ≥1 wk + worse/much worse purulence.
e EPOS S CRS status determined using baseline and fall exacerbation questionnaires: current long-term CRS = EPOS epidemiologic criteria fulfilled at both questionnaires; current recent CRS = current CRS at fall questionnaire, but not at baseline; past CRS = EPOS epidemiologic criteria fulfilled in lifetime, but not during study; never CRS = EPOS epidemiologic criteria never met. f Population-estimates were derived using survey-corrected methods with robust standard error estimation. Although overall prevalence estimates for AENSS-Med and -SxPur were comparable, there was little overlap in individuals ascertained by the 2 definitions, with only 31% of AENSS-Sx-Pur events additionally meeting criteria for AENSS-Med (see Table S5 ). Discordance could be due to AENSS-Med being influenced by an individual's propensity to seek and be provided with medical care.
AENSS occurred in all CRS status groups, but prevalence was higher and severity worse among subjects with past or current (longterm and recent) CRS. The absolute change in severity during an AENSS was largest among subjects who never met EPOS S CRS criteria, possibly due to a ceiling effect in NSS severity among individuals with current or past CRS.
AENSS prevalence was greatest in the winter and spring for the past and never CRS groups, respectively, across all 3 AENSS definitions. This suggests exacerbations might be driven by viral infections Adjusted estimates from survey-corrected logistic regression models with robust standard error estimation.
c EPOS S CRS status determined using baseline and fall exacerbation questionnaires: current long-term CRS = EPOS epidemiologic criteria fulfilled at both questionnaires; current recent CRS = current CRS at fall questionnaire, but not at baseline; past CRS = EPOS epidemiologic criteria fulfilled in lifetime, but not during study; never CRS = EPOS epidemiologic criteria never met. Adjusted estimates from survey-corrected logistic regression models with robust standard error estimation.
c EPOS S CRS status determined using baseline and fall exacerbation questionnaires: current long-term CRS = EPOS epidemiologic criteria fulfilled at both questionnaires; current recent CRS = current CRS at fall questionnaire, but not at baseline; past CRS = EPOS epidemiologic criteria fulfilled in lifetime, but not during study; never CRS = EPOS epidemiologic criteria never met. *P-value <.05; **P-value <.01; ***P-value <.001.
white race/ethnicity was associated with reduced odds of both AENSS definitions, though only statistically significant in the AENSS-Sx-Pur model. Lastly, never smokers were less likely to have AENSS-Med, compared to current smokers, although no association with smoking status and AENSS-Sx-Pur was observed. The odds of AENSS-Sx-Pur declined with higher ages, excluding the current long-term CRS status group, possibly due to differential susceptibility to viral infections which precede bacterial infections and decrease with increasing age. 42 Yet, individuals with long-term CRS may be at risk of developing viral respiratory infections even at older ages due to compromised epithelial barrier function, 43, 44 which can accompany CRS, 1,2,45 suggestive of a disease progressive model in those with persistent CRS.
Our study had several strengths, including study of the general population in the region representing the full spectrum of diseases with NSS, longitudinal design (the first to our knowledge), large sample size, and evaluation of a relevant set of individual-reported potential risk factors for AENSS, as well as season. We also used several definitions of AENSS to comparatively assess their utility in epidemiologic research, as advised by ICAR. 2 Our study is not without limitations, however. We used a definition of CRS which did not include confirmation of inflammation by endoscopy or CT scan so we were unable to classify individuals with clinical CRS. Second, both CRS status and self-reported individual characteristics were selected from the same questionnaires; as such, there is the potential for spurious associations between them, as they are dependent on how an individual interprets and responds to the questions.
However, a strength of this study is the inclusion of the ASI as a covariate, which adjusts for an individual's propensity to over-report symptoms and comorbidities. Therefore, the possibility of false associations from same source bias was mitigated. Furthermore, we used weighting methods and multiple imputation to adjust for nonresponse and potential selection bias.
In summary, our study found that NSS and AENSS were common in the general population. NSS and AENSS severity were 
